MS Relative Valuation
MS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MS is overvalued; if below, it's undervalued.
Historical Valuation
Morgan Stanley (MS) is now in the Overvalued zone, suggesting that its current forward PE ratio of 17.35 is considered Overvalued compared with the five-year average of 13.90. The fair price of Morgan Stanley (MS) is between 147.35 to 178.79 according to relative valuation methord. Compared to the current price of 184.68 USD , Morgan Stanley is Overvalued By 3.29%.
Relative Value
Fair Zone
147.35-178.79
Current Price:184.68
3.29%
Overvalued
17.35
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Morgan Stanley. (MS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
NaN
EV/EBIT
Morgan Stanley. (MS) has a current EV/EBIT of NaN. The 5-year average EV/EBIT is NaN. The thresholds are as follows: Strongly Undervalued below NaN, Undervalued between NaN and NaN, Fairly Valued between NaN and NaN, Overvalued between NaN and NaN, and Strongly Overvalued above NaN. The current Forward EV/EBIT of NaN falls within the range.
3.91
PS
Morgan Stanley. (MS) has a current PS of 3.91. The 5-year average PS is 2.86. The thresholds are as follows: Strongly Undervalued below 2.10, Undervalued between 2.10 and 2.48, Fairly Valued between 3.24 and 2.48, Overvalued between 3.24 and 3.62, and Strongly Overvalued above 3.62. The current Forward PS of 3.91 falls within the Strongly Overvalued range.
0.00
P/OCF
Morgan Stanley. (MS) has a current P/OCF of 0.00. The 5-year average P/OCF is 9.45. The thresholds are as follows: Strongly Undervalued below -17.93, Undervalued between -17.93 and -4.24, Fairly Valued between 23.14 and -4.24, Overvalued between 23.14 and 36.82, and Strongly Overvalued above 36.82. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Morgan Stanley. (MS) has a current P/FCF of 0.00. The 5-year average P/FCF is 10.90. The thresholds are as follows: Strongly Undervalued below -19.15, Undervalued between -19.15 and -4.12, Fairly Valued between 25.92 and -4.12, Overvalued between 25.92 and 40.95, and Strongly Overvalued above 40.95. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Morgan Stanley (MS) has a current Price-to-Book (P/B) ratio of 2.89. Compared to its 3-year average P/B ratio of 1.90 , the current P/B ratio is approximately 52.19% higher. Relative to its 5-year average P/B ratio of 1.80, the current P/B ratio is about 60.76% higher. Morgan Stanley (MS) has a Forward Free Cash Flow (FCF) yield of approximately -2.33%. Compared to its 3-year average FCF yield of -13.06%, the current FCF yield is approximately -82.14% lower. Relative to its 5-year average FCF yield of -7.52% , the current FCF yield is about -68.97% lower.
2.89
P/B
Median3y
1.90
Median5y
1.80
-2.33
FCF Yield
Median3y
-13.06
Median5y
-7.52
Competitors Valuation Multiple
The average P/S ratio for MS's competitors is 7.60, providing a benchmark for relative valuation. Morgan Stanley Corp (MS) exhibits a P/S ratio of 3.91, which is -48.51% above the industry average. Given its robust revenue growth of 14.20%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MS increased by 35.46% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 12.29 to 15.53.
The secondary factor is the Revenue Growth, contributed 14.20%to the performance.
Overall, the performance of MS in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is Morgan Stanley (MS) currently overvalued or undervalued?
Morgan Stanley (MS) is now in the Overvalued zone, suggesting that its current forward PE ratio of 17.35 is considered Overvalued compared with the five-year average of 13.90. The fair price of Morgan Stanley (MS) is between 147.35 to 178.79 according to relative valuation methord. Compared to the current price of 184.68 USD , Morgan Stanley is Overvalued By 3.29% .
What is Morgan Stanley (MS) fair value?
MS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Morgan Stanley (MS) is between 147.35 to 178.79 according to relative valuation methord.
How does MS's valuation metrics compare to the industry average?
The average P/S ratio for MS's competitors is 7.60, providing a benchmark for relative valuation. Morgan Stanley Corp (MS) exhibits a P/S ratio of 3.91, which is -48.51% above the industry average. Given its robust revenue growth of 14.20%, this premium appears unsustainable.
What is the current P/B ratio for Morgan Stanley (MS) as of Jan 09 2026?
As of Jan 09 2026, Morgan Stanley (MS) has a P/B ratio of 2.89. This indicates that the market values MS at 2.89 times its book value.
What is the current FCF Yield for Morgan Stanley (MS) as of Jan 09 2026?
As of Jan 09 2026, Morgan Stanley (MS) has a FCF Yield of -2.33%. This means that for every dollar of Morgan Stanley’s market capitalization, the company generates -2.33 cents in free cash flow.
What is the current Forward P/E ratio for Morgan Stanley (MS) as of Jan 09 2026?
As of Jan 09 2026, Morgan Stanley (MS) has a Forward P/E ratio of 17.35. This means the market is willing to pay $17.35 for every dollar of Morgan Stanley’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Morgan Stanley (MS) as of Jan 09 2026?
As of Jan 09 2026, Morgan Stanley (MS) has a Forward P/S ratio of 3.91. This means the market is valuing MS at $3.91 for every dollar of expected revenue over the next 12 months.